Skip to search formSkip to main contentSkip to account menu

Fenretinide

Known as: N-(4-Hydroxyphenyl)All-Trans Retinamide, 4-hydroxyphenylretinamide, N-(4-Hydroxyphenyl)-trans-Retinamide 
An orally-active synthetic phenylretinamide analogue of retinol (vitamin A) with potential antineoplastic and chemopreventive activities. Fenretinide… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Abstract Cancer chemopreventive agents such as N-4-(hydroxyphenyl)retinamide (4HPR) are thought to prevent cancers by suppressing… 
Highly Cited
2005
Highly Cited
2005
Pancreatic cancer is exceptionally aggressive with no long-term effective therapy. Current interventional approaches, including… 
Review
1996
Review
1996
N‐(4‐Hydroxyphenyl) retinamide (4HPR) and retinoyl beta‐glucuronide (RAG) are two derivatives of all‐trans retinoic acid (RA… 
Highly Cited
1989
Highly Cited
1989
Fenretinide (HPR) is a synthetic retinoid which has been shown to cause a reduction in the incidence of carcinogen-induced… 
Highly Cited
1986
Highly Cited
1986
Five patients with basal cell carcinoma received fenretinide. Two patients while receiving the drug had evidence of abnormal rod… 
Highly Cited
1985
Highly Cited
1985
The synthetic retinoid 4-hydroxyphenylretinamide (HPR) showed antiproliferative effect on cultured human breast cancer cells… 
Highly Cited
1982
Highly Cited
1982
Bilateral ovariectomy and dietary administration of the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are both effective… 
Highly Cited
1982
Highly Cited
1982
A series of experiments was conducted to determine the efficacy of 15 synthetic retinoic acid amides (retinamides) as inhibitors…